Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
Delayed Quote. Delayed Nyse - 01/26 04:10:00 pm
53.01 USD   +0.89%
01:21aPfizer tests omicron vaccine in humans
AQ
01/27PFIZER, INC. : Ex-dividend day for
FA
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer Initiates Filling of Rolling New Drug Submission With Health Canada For COVID-19 Oral Antiviral Candidate

12/01/2021 | 03:14pm EST


ę MT Newswires 2021
All news about PFIZER, INC.
01:21aPfizer tests omicron vaccine in humans
AQ
01/27PFIZER, INC. : Ex-dividend day for
FA
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
01/26Pfizer Seeks Role in US COVID-19 Vaccine Litigation to Protect Trade Secrets
MT
01/26Moderna starts trial for Omicron-specific booster shot
RE
01/26Health Care Down On Growth Doubts -- Health Care Roundup
DJ
01/26European shares show signs of recovery as Fed meeting awaited
RE
01/26COVID-19 cases at highest ever in Americas -regional health agency
RE
01/26GLOBAL MARKETS LIVE : Vodafone, Qualcomm, Microsoft, Tesla, Intel...
01/26U.S. has shipped 400 mln COVID vaccine doses worldwide -White House
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 839 M - -
Net income 2021 22 216 M - -
Net Debt 2021 27 401 M - -
P/E ratio 2021 13,9x
Yield 2021 2,99%
Capitalization 298 B 298 B -
EV / Sales 2021 3,97x
EV / Sales 2022 3,06x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 53,01 $
Average target price 57,88 $
Spread / Average Target 9,19%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-10.23%297 538
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642
NOVO NORDISK A/S-15.89%213 450